-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on Protagonist Therapeutics, Raises Price Target to $173

Benzinga·08/10/2026 14:50:51
Listen to the news
Wedbush analyst Yun Zhong maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Outperform and raises the price target from $118 to $173.